Tech Center 1600 • Art Units: 1644 1646 1649 1678 1699
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17913629 | MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF | Non-Final OA | AMGEN INC. |
| 17629445 | IMMUNE CELLS EXPRESSING MODIFIED CELL RECEPTORS AND METHODS OF MAKING | Final Rejection | CARTHERICS PTY. LTD. |
| 18019228 | COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17314376 | SARS-COV-2 IMMUNOASSAY AND MATERIALS THEREFOR | Final Rejection | BIO-RAD LABORATORIES, INC. |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16302429 | ACOUSTIC SEPARATION FOR BIOPROCESSING | Final Rejection | THE CHARLES STARK DRAPER LABORATORY, INC. |
| 17705924 | Methods for Detecting Symmetrical Dimethylarginine | Non-Final OA | IDEXX Laboratories, Inc. |
| 17793319 | FLUORESCENTLY-LABELED F-ACTIN PROTEIN BIOSENSORS AND METHODS OF HIGH-THROUGHPUT DRUG DISCOVERY | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18956170 | METHOD FOR DETECTION OF CELLS BY REPETITIVE STAINING AND DESTAINING | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
| 17790876 | METHODS FOR INFORMATION TRANSFER AND RELATED KITS | Non-Final OA | ENCODIA, INC. |
| 17922074 | UNBLENDING OF TRANSCRIPTIONAL CONDENSATES IN HUMAN REPEAT EXPANSION DISEASE | Non-Final OA | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
| 17631598 | ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER | Final Rejection | Medizinische Hochschule Hannover |
| 18734732 | Capture Beads for Use in Assays | Non-Final OA | Zafrens Inc. |
| 18538543 | LUNG CANCER BIOMARKERS | Non-Final OA | Meso Scale Technologies, LLC. |
| 18118432 | DIAGNOSTIC METHODS FOR LIVER DISORDERS | Final Rejection | Meso Scale Technologies, LLC. |
| 18248505 | PROTEOME ANALYSIS IN PULMONARY HYPERTENSION | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18025763 | Methods of Determining Immune Response | Non-Final OA | The Council of the Queensland Institute of Medical Research |
| 18532159 | ANTIBODIES AND METHODS FOR THE DETECTION OF CELL DEATH | Non-Final OA | PHARMA CINQ, LLC |
| 18259727 | SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES | Non-Final OA | Johns Hopkins University |
| 18265584 | METHOD FOR PREDICTING THE FERTILITY POTENTIAL OF A FEMALE SUBJECT | Non-Final OA | Rigshospitalet |
| 17605656 | METHOD FOR DIAGNOSING ENDOMETRIOSIS, DISEASE STATE MONITORING METHOD, AND KIT | Non-Final OA | National Institutes of Biomedical Innovation, Health and Nutrition |
| 17257968 | Methods for Multicolor Multiplex Imaging | Non-Final OA | Ultivue, Inc. |
| 18311895 | METHODS OF ISOLATING AND DETECTING VIRUSES FROM LIQUID WITH POSSIBILITY OF CONTAINING VIRUSES | Non-Final OA | JNC CORPORATION |
| 17794768 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY | Final Rejection | Dyne Therapeutics, Inc. |
| 18068872 | COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS | Non-Final OA | AMUNIX PHARMACEUTICALS, INC. |
| 18058171 | MULTIPLEXED FLUORESCENCE IN SITU HYBRIDIZATION METHOD CAPABLE OF RAPID DETECTION OF BILLIONS OF TARGETS | Non-Final OA | Kanvas Biosciences, Inc. |
| 17937251 | SURFACE FUNCTIONALIZED AFFINITY MEMBRANES | Non-Final OA | NANOPAREIL, LLC |
| 17692804 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | Non-Final OA | BERTIS CO., LTD. |
| 17593922 | METHOD OF USING FOLLISTATIN IN TYPE 2 DIABETES RISK PREDICTION | Final Rejection | LUNDOCH DIAGNOSTICS AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy